Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Dynamin 2 regulates biphasic insulin secretion and plasma glucose homeostasis
Fan Fan, … , Louis H. Philipson, Xuelin Lou
Fan Fan, … , Louis H. Philipson, Xuelin Lou
Published September 28, 2015
Citation Information: J Clin Invest. 2015;125(11):4026-4041. https://doi.org/10.1172/JCI80652.
View: Text | PDF
Research Article Endocrinology

Dynamin 2 regulates biphasic insulin secretion and plasma glucose homeostasis

  • Text
  • PDF
Abstract

Alterations in insulin granule exocytosis and endocytosis are paramount to pancreatic β cell dysfunction in diabetes mellitus. Here, using temporally controlled gene ablation specifically in β cells in mice, we identified an essential role of dynamin 2 GTPase in preserving normal biphasic insulin secretion and blood glucose homeostasis. Dynamin 2 deletion in β cells caused glucose intolerance and substantial reduction of the second phase of glucose-stimulated insulin secretion (GSIS); however, mutant β cells still maintained abundant insulin granules, with no signs of cell surface expansion. Compared with control β cells, real-time capacitance measurements demonstrated that exocytosis-endocytosis coupling was less efficient but not abolished; clathrin-mediated endocytosis (CME) was severely impaired at the step of membrane fission, which resulted in accumulation of clathrin-coated endocytic intermediates on the plasma membrane. Moreover, dynamin 2 ablation in β cells led to striking reorganization and enhancement of actin filaments, and insulin granule recruitment and mobilization were impaired at the later stage of GSIS. Together, our results demonstrate that dynamin 2 regulates insulin secretory capacity and dynamics in vivo through a mechanism depending on CME and F-actin remodeling. Moreover, this study indicates a potential pathophysiological link between endocytosis and diabetes mellitus.

Authors

Fan Fan, Chen Ji, Yumei Wu, Shawn M. Ferguson, Natalia Tamarina, Louis H. Philipson, Xuelin Lou

×

Figure 2

Dynamin 2 is required to maintain normal plasma glucose homeostasis in vivo.

Options: View larger image (or click on image) Download as PowerPoint
Dynamin 2 is required to maintain normal plasma glucose homeostasis in v...
(A) Scheme of temporally controlled, β cell–specific Dnm2 KO. Tamoxifen triggers the translocation of Cre recombinase driven by the MIP promoter into the nucleus and deletes Dnm2 in β cells. (B and C) Efficient dynamin 2 deletion in Dnm2 KO β cells demonstrated by (B) Western blots and (C) immunohistochemistry. Scale bar: 20 μm. (D) Similar body weight between control and KO mice (n = 13 for each group). (E) Significant glucose intolerance in Dnm2 KO mice compared with different controls (n = 11–13 mice for each group). (F) AUC of GTT curves (P = 0.039, 1-way ANOVA with Tukey honest significant difference). (G) ITTs (n = 8–9 mice for each group). (H–K) Body weight, GTT, and ITT after high-fat diet feeding (n = 6–8 mice for each group). (L and M) Similar body weight but significant glucose intolerance in Dnm2 KO mice following 3 glucose injections (every 30 minutes as indicated by arrows); n = 6 mice for each group except Dnm2fl/fl plus tamoxifen (n = 5). (N) AUC comparison of GTT curves in M (P = 0.003, 1-way ANOVA). Unpaired 2-tailed Student’s t tests were used unless specified. T, tamoxifen; V, vehicle. *P < 0.05, **P < 0.01, ***P < 0.005.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts